ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
54.00
-0.54
(-0.99%)
Closed November 04 4:00PM
54.00
0.00
( 0.00% )
Pre Market: 8:58AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
54.00
Bid
53.00
Ask
54.00
Volume
1
0.00 Day's Range 0.00
43.62 52 Week Range 59.24
Market Cap
Previous Close
54.00
Open
-
Last Trade
1
@
54.86
Last Trade Time
04:23:49
Financial Volume
-
VWAP
-
Average Volume (3m)
589,752
Shares Outstanding
88,112,466
Dividend Yield
2.44%
PE Ratio
9.54
Earnings Per Share (EPS)
5.66
Revenue
23.76B
Net Profit
498.7M

About Avnet Inc

Avnet is a global distributor of electronic components, connecting suppliers of semiconductors and other components to a base of 2.1 million small- and mid-sized customers in 140 countries. Avnet is the third largest semiconductor distributor in the world, and the largest for European chip distribut... Avnet is a global distributor of electronic components, connecting suppliers of semiconductors and other components to a base of 2.1 million small- and mid-sized customers in 140 countries. Avnet is the third largest semiconductor distributor in the world, and the largest for European chip distribution. Avnet services all levels of electronics design and development, servicing engineers with design tools, test kits, and services alongside its high-volume distribution for final designs. Show more

Sector
Electronic Parts,eq-whsl,nec
Industry
Electronic Parts,eq-whsl,nec
Website
Headquarters
Albany, New York, USA
Founded
-
Avnet Inc is listed in the Electronic Parts,eq-whsl sector of the NASDAQ with ticker AVT. The last closing price for Avnet was $54. Over the last year, Avnet shares have traded in a share price range of $ 43.62 to $ 59.24.

Avnet currently has 88,112,466 shares outstanding. The market capitalization of Avnet is $4.76 billion. Avnet has a price to earnings ratio (PE ratio) of 9.54.

AVT Latest News

Avnet Reports First Quarter 2025 Financial Results

First quarter sales of $5.6 billion and diluted EPS of $0.66 Adjusted diluted EPS of $0.92 Cash flow from operations of $838 million over past four quarters Avnet, Inc. (Nasdaq: AVT) today...

Dave Youngblood Joins Avnet as Chief Digital Officer

Youngblood joins Avnet’s executive leadership team to drive distributor’s digital strategy Avnet (Nasdaq: AVT) has hired Dave Youngblood as Chief Digital Officer, effective October 21, 2024. In...

Avnet to Report First Quarter Fiscal Year 2025 Earnings on October 30

Conference call and webcast to follow at 9:00 a.m. PT / Noon ET Avnet (Nasdaq: AVT), a global technology solutions company, today announced it will report financial results for the first quarter...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1005459.2453.845108121555.38834219CS
40.060.11123470522853.9459.2453.3464287554.86579028CS
120.881.6566265060253.1259.2448.1558975253.80413476CS
264.078.1514119767749.9359.2448.1560029053.20369146CS
527.4716.054158607446.5359.2443.6258207250.39986029CS
15614.6137.090632140139.3959.2435.4564975245.52212154CS
26012.7130.782271736541.2959.2417.8571423240.36736247CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BNOXBionomics Ltd
$ 0.4844
(153.30%)
117.71M
ALBTAvalon GloboCare Corporation
$ 4.21
(87.95%)
22.1M
AGFYAgrify Corporation
$ 5.55
(76.75%)
10.91M
ZVSAZyVersa Therapeutics Inc
$ 3.08
(69.23%)
18.57M
SPPLSIMPPLE Ltd
$ 1.64
(38.98%)
24.77M
MQMarqeta Inc
$ 3.90
(-34.45%)
3.75M
VRCAVerrica Parmaceuticals Inc
$ 0.95
(-33.57%)
100.25k
EPRXEupraxia Pharmaceuticals Inc
$ 2.65
(-23.74%)
37
HUBCWHub Cyber Security Ltd
$ 0.0102
(-20.93%)
1.2k
CVGICommercial Vehicle Group Inc
$ 2.51
(-18.51%)
20.71k
ELABElevai Labs Inc
$ 0.0242
(20.40%)
182.19M
BNOXBionomics Ltd
$ 0.4845
(153.35%)
117.72M
SPPLSIMPPLE Ltd
$ 1.64
(38.98%)
24.77M
ALBTAvalon GloboCare Corporation
$ 4.21
(87.95%)
22.1M
ZVSAZyVersa Therapeutics Inc
$ 3.06
(68.13%)
18.59M

Discussion

View Full Feed
Bigtrade PT Bigtrade PT 4 minutes ago
I don't believe in this climb... it's going to fall more...
ELAB
$treet Trader $treet Trader 5 minutes ago
Good morning A$ & LD
Screech691 Screech691 5 minutes ago
love SGTM's commitment to sustainability with their living mulch product
COMMITTED TO SUSTAINABILITY
Microbe Living Mulch delivers impressive outcomes for your landscape, including enhanced aesthetic appeal and increased yields for healthier gardens. It aids in carbon sequestration, im
SGTM
02opida 02opida 5 minutes ago
VOTE America
$treet Trader $treet Trader 5 minutes ago
Good morning .0001ers
JettaR JettaR 5 minutes ago
Poor abandoned child. 
CBDW
getmoreshares getmoreshares 5 minutes ago
https://x.com/woofknight/status/1853787152342999283
Midwestrader Midwestrader 5 minutes ago
Evidently that CLOWN CAR CEO never really did DD and research on what happens with the pps after a REVERSE SPLIT. He probably thought it would drop a few cents and he'd be DUMPING away at say....0.35. 🤣 🤪

Nah...this POS CON JOB SHAM is now down 78.94% as of close yest
INND
docj docj 6 minutes ago
New SAB member:
Clinton Yam, MD, MS
Dr. Clinton Yam is an Associate Professor with dual appointments in the Departments of Breast Medical Oncology and Translational Molecular Pathology at The University of Texas MD Anderson Cancer Center. Dr. Yam is leader of the triple-negative breast
CYDY
02opida 02opida 6 minutes ago
Good Morning America
BigBadWolf BigBadWolf 6 minutes ago
$ASIInvestors Learned long ago [yt]Wxk1cyYJe-o[/yt]
My $ I base it's use on my DD & highly recommend both the aforementioned to all
ASIINVESTO
getmoreshares getmoreshares 6 minutes ago
https://x.com/woofknight/status/1853787152342999283
StayHumble StayHumble 6 minutes ago
🚩🚩 Hearing there’s a Massive Reverse Split 🚩🚩Coming
https://i.imgflip.com/7idht1.jpg
DJT
jjjjjjjj jjjjjjjj 6 minutes ago
Good buys of 28M shares but only last minute buys will work! All short sellers have no more shares to borrow. They fake the shares by claiming settlement days. Keep doing
1. SET SELL HIGH our shares,
2. SET BUY HIGH at last minute with price limit.
Our time will come unst
MJNA
Eli's Gone Eli's Gone 6 minutes ago
sure LOL---and the Chevys weren't blocking for Byron and Bubba "thinks" something broke just before he allowed fellow Toyota driver Bell to pass him for the crucial 1 point needed....

a few peeps might pay after NASCAR goes over the radio traffic among those teams involved
SHEEPWOLF SHEEPWOLF 6 minutes ago
$ILLR AMONG PREMARKET GAINERS
#TRILLER IS READY TO TAKE OFF↗️
https://investorshub.advfn.com/uimage/uploads/2024/11/5/thfegGAINERS.png
ILLR
Mr.Wolf Mr.Wolf 6 minutes ago
oh contrar. Go to the Q3 management report and look at QoQ sales. Q2 growth was 400%, if you account for 1/3 of Q3 sales being offline the sales would have been approx: $358,000 ($236k/.66). which is 43% sales growth. People like and were buying the product. The challenge is how much customer loyalt
PSYCF
SHEEPWOLF SHEEPWOLF 6 minutes ago
$ILLR AMONG PREMARKET GAINERS
#TRILLER IS READY TO TAKE OFF↗️
https://investorshub.advfn.com/uimage/uploads/2024/11/5/thfegGAINERS.png
ILLR
docj docj 7 minutes ago
Who says they don't? We'll find out in due time. The trial does't start until early next year.
CYDY
TJG TJG 7 minutes ago
It seems there was an update on the Share Structure on Oct 23 Lets see if there are any differences and what they may be

OS is up 200 million and the unrestricted is up 20 million Held at DTC is the same

Oct 23

AFFU Security Details
Share Structur
AFFU DTC
TKS PARTY TKS PARTY 7 minutes ago
Any news at this point will be highly appreciated !!!!!!
CBRF
georgie18 georgie18 7 minutes ago
ALLO...$2.98...News...ALLO-316, an “Off-the-Shelf” AlloCAR T™ Anti-CD70 CAR T Product, is Currently Under Investigation in the Phase 1 TRAVERSE Trial for Patients with Renal Cell Carcinoma (RCC) Previously Treated with Immune Checkpoint Inhibitors and VEGF-Targeting Therapies
Data Presented A
ALLO
GMH* GMH* 7 minutes ago
Link to abstract:
https://jitc.bmj.com/content/12/Suppl_3/A1718
Key take-away:

At a median follow-up of 25.6 months, the ORR (95% CI) in the EGFR-wt subgroup of interest for further studies was 64.3% (35.1%–87.2%). Median DOR in this subgroup was not reached (NR; 95% CI,
IOVA